REFERENCES
- Tallman M S, Andersen J W, Schiffer C A, et al. All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021–1028
- Larson RS, Tallmann MS. Retinoic acid syndrome: manifestations, pathogenesis and treatment. Best Pract Res Clin Hematol 2003; 16: 453–461
- Avvisati G, Coco FL, Mandelli F. Acute promyelocytic leukemia: clinical and morphological features and prognostic factors. Semin Hematol 2001; 38: 4–12
- Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 2001; 38: 13–25
- Vanier K L, Mattiussi A, Johnston D L. Interaction of all-trans retinoic acid with fluconazole in acute promyelocytic leukemia. J Pediatr Hematol Oncol 2003; 25: 403–404
- Testi A M, Biondi A, Lo Coco M, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 2005; 106: 447–453
- Bergstein J M. Toxic nephropathies–renal failure. Nelson Textbook of Pediatrics RE Behrman, RM Kliegman, AM Arvin. Saunders, Philadelphia 1996; 1513–1518
- Hoitsma A J, Wetzels J F, Koene R A. Drug-induced nephrotoxicity: aetiology, clinical features and management. Drug Saf 1991; 6: 131–147
- Schwartz E L, Hallam S, Gallagher R E, Wiernik P H. Inhibition of all-trans retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem Pharmacol 1995; 28: 923–928
- Menegola E, Broccia M L, Di Renzo F, Massa V, Giavini E. Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in vitro. Rep Toxicol 2004; 18: 121–130